The Special Meeting has now been held. Click here to read a press release detailing the outcome.

Venture Capital Capabilities

Pender Ventures invests in B2B and health-tech companies with a thesis-driven, series-agnostic approach and a geographical focus on Canadian companies. 

Pender Ventures invests in a concentrated selection of B2B and health-focused technology companies at their inflection point to scale, applying a scale-up framework and diversity influence aimed at driving top-quartile returns and creating tangible impact.

We focus on the stage of the company, rather than an arbitrary series, where we see:

Commercialized product(s) with early customer or partner revenue ($2-$5 million in revenue).

Clear understanding of the drivers of the business.

Capital efficient.

Well-defined path to liquidity.

We also focus on investing in companies that are:

Resilient

Need to have vs. nice to have technology.

Capital Efficient

Strong unit economics and a clear path to profitability.

High ROI Products

Products that increase revenue, decrease costs and/or improve outcomes.

Meet the Team

Maria Pacella
Managing Partner
View Profile
Meryeme Lahmami
Principal
View Profile
Lynn Frazer
Head of People Strategy
View Profile
Jacob Granger
Associate
View Profile
Everett Juurlink
Analyst
View Profile
Tony Rautava
Manager of Fund Operations
View Profile

Visit Pender Ventures

Penderventures.com

Sign Me Up

Receive a hand-picked selection of our latest insights monthly, straight to your inbox.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Email Opt In

© 2025 PenderFund Capital Management Ltd. All Rights Reserved.
crossmenuchevron-downchevron-rightchevron-up-circle linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram